Robert Harris Schwartz - 08 Mar 2024 Form 4 Insider Report for Anterix Inc. (ATEX)

Role
President and CEO, Director
Signature
s/ Gena L. Ashe, Attorney-in-Fact
Issuer symbol
ATEX
Transactions as of
08 Mar 2024
Transactions value $
$0
Form type
4
Filing time
12 Mar 2024, 20:48:18 UTC
Previous filing
25 Aug 2023
Next filing
03 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATEX Common Stock Award $0 +21,528 +23% $0 114,467 08 Mar 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATEX Stock Option (Right to Buy) Award $0 +127,189 $0 127,189 08 Mar 2024 Common Stock 127,189 $36 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the issuance of restricted stock units (the "RSUs"). 1/3 of the RSUs vest on May 22, 2025, with the remaining RSUs vesting in 2 equal annual installments thereafter.
F2 1/3 of the option shares vest and become exercisable on May 22, 2025, with the remaining option shares vesting in 2 equal annual installments thereafter.